ECDC risk assessment: 2009 influenza A(H1N1) pandemic (Update 6 November 2009)
This update of ECDC pandemic risk assessment for Europe is based on data and analyses available in early November 2009. It draws on the experience in European countries, North America and the Southern Hemisphere’s temperate countries, which have already passed through a winter with the new virus.
CNRL in silico exercise to determine the capabilities of network laboratories to detect triple reassortant swine origin influenza A(H3N2) viruses
Following the emergence of swine influenza A(H3N2) variant (v) viruses with sporadic human infections in North America, the Community Network of Reference Laboratories (CNRL) and the Animal Health and Veterinary Laboratories Agency completed an exercise to assess the CNRL’s capability to detect novel reassortant and circulating triple reassortant swine viruses (TRA) in humans.
Rapid risk assessment: Risk related to the use of ‘do-it-yourself' CRISPR-associated gene engineering kit contaminated with pathogenic bacteria
On 24 March 2017, the German authorities reported the contamination of a ‘do-it-yourself’ bacterial gene engineering CRISPR kit produced in the US. This publication assesses the risk related to the use of ‘do-it-yourself’ CRISPR-associated gene engineering kit contaminated with pathogenic bacteria.
Rapid risk assessment: Cyclospora infections in European travellers returning from Mexico - 21 July 2017
Assessment of the prolonged outbreak of Cyclospora infections in Mexico which has been affecting European travellers for at least three consecutive years.